Sja. Aerdts et al., METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS OF SELECTIVE DECONTAMINATION OF THE DIGESTIVE-TRACT, BMJ. British medical journal, 307(6903), 1993, pp. 525-532
Objective-To determine the clinical benefits of selective decontaminat
ion of the digestive tract in patients treated in intensive care units
. Design-Meta-analysis of 22 randomised trials that compared different
combinations of oral non-absorbable antibiotics, with or without a sy
stemic component, with no treatment in controls. Subjects-4142 patient
s seen in general and specialised intensive care units around the worl
d. 2047 received some form of antibiotic treatment, the remainder no p
rophylaxis. Data analysis-Each trial was reviewed through direct conta
ct with study investigators. Data collected were: the randomisation pr
ocedure, number of patients, number excluded from the analysis, and nu
mbers of respiratory tract infections and deaths. Data were combined a
ccording to an intention to treat analysis with the Mantel-Haenszel-Pe
to method. Main outcome measures-Respiratory tract infections and tota
l mortality. Results-Selective decontamination of the digestive tract
significantly reduced respiratory tract infections (odds ratio 0.37; 9
5% confidence interval 0.31 to 0.43). The value of the common odds rat
io for total mortality (0.90; 0.79 to 1.04) suggested at best a modera
te treatment effect, reaching statistical significance only when the s
ubgroup of trials of topical and systemic treatment combined was consi
dered separately (odds ratio 0.80; 0.67 to 0.97). No firm conclusions
could be drawn owing to large variations in patient mix and severity w
ithin and between trials. Conclusions-The findings strongly indicate t
hat selective decontamination significantly reduces infection related
morbidity in patients receiving intensive care. They also highlight wh
y definite conclusions about the effect of prophylaxis on mortality ca
nnot be drawn despite the large number of trials available. Based on t
he most favourable results obtained by pooling data from trials in whi
ch combined topical and systemic treatment was used it may be estimate
d that 6 (range 5-9) and 23 (13-139) patients would need to be treated
to prevent one respiratory tract infection and one death respectively
.